Advanced Accelerator Applications
Thomas Groeschner has a diverse work experience in the pharmaceutical industry. Thomas is currently the Global Head QC/AS&T at Advanced Accelerator Applications, where they are responsible for driving and maintaining compliant and efficient QC testing labs. From 2017 to 2020, they worked as the Global Digital Quality Control Program Director at Novartis. Prior to that, they held positions at Sandoz, Barr Pharmaceuticals, Teva Pharmaceuticals, Barr Laboratories Inc, and Schein Pharmaceuticals, where they gained experience in roles such as Director of Quality Control and Analytical Science and Technology, Associate Director of IT Lab Applications, Manager of IT Laboratory Applications, Manager of QC, and AR&D Technical Group Leader. In these roles, they managed teams, set up QC labs, and ensured the smooth functioning of lab operations.
Thomas Groeschner attended Old Dominion University from 1986 to 2001, earning a Bachelor of Science (BS) degree in Biology/Chemistry.
This person is not in any offices
Advanced Accelerator Applications
We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine.